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The emergence of HIV-1 group M subtype B in North American men who have sex 23 
with men (MSM) was a key turning point in the HIV/AIDS pandemic. Phylogenetic 24 
studies have suggested cryptic subtype B circulation in the United States (US) 25 
throughout the 1970s2,3 and an even older presence in the Caribbean3. However, 26 
these timing and geographical inferences, based upon partial HIV-1 genomes that 27 
postdate the recognition of AIDS in 1981, remain contentious1,4 and the earliest 28 
movements of the virus within the US are unknown. We serologically screened 29 
>2000 1970s serum samples and developed a highly sensitive new approach for 30 
recovering viral RNA from degraded archival samples. Here, we report eight 31 
coding-complete genomes from US serum samples from 1978-79 – eight of the 32 
nine oldest HIV-1 group M genomes to date. This early, full-genome ‘snapshot’ 33 
reveals the US HIV-1 epidemic exhibited surprisingly extensive genetic diversity in 34 
the 1970s but also provides strong evidence of its emergence from a pre-existing 35 
Caribbean epidemic. Bayesian phylogenetic analyses estimate the jump to the US 36 
at ~1970 and place the ancestral US virus in New York City with 0.99 posterior 37 
probability support, strongly suggesting this was the crucial hub of early US 38 
HIV/AIDS diversification. Logistic growth coalescent models reveal epidemic 39 
doubling times of 0.86 and 1.12 years for the US and Caribbean, respectively, 40 
suggesting rapid early expansion in each location1. Comparisons with more recent 41 
data reveal many of these insights to be unattainable without archival, full-genome 42 
sequences. We also recovered the HIV-1 genome from the individual known as 43 
‘Patient 0’5 and show there is neither biological nor historical evidence he was the 44 
primary case in the US or for subtype B as a whole. We discuss the genesis and 45 
persistence of this belief in the light of these evolutionary insights. 46 
 47 
No comprehensive genomic analysis of the emergence and early spread 48 
of HIV-1 in North America – where HIV/AIDS was first recognized – has been 49 
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possible because the only pre-1980 HIV-1 group M genome currently available 50 
(strain Z321B) was sampled in Africa. To fill this gap, we performed serological 51 
screening and viral genome sequencing of archived serum samples dating back 52 
to 1978-79, originally collected from MSM cohort patients in New York City (NYC) 53 
and San Francisco (SF). NYC samples were from volunteers in a prospective 54 
study of AIDS established in 19846, 378 of whom had been part of an earlier 55 
cohort of 8906 men involved in hepatitis B virus (HBV) studies beginning in 56 
19787, and for which stored sera from 1978 and/or 1979 were available8. 57 
Previous work showed that 6.6% of these sera from NYC in 1978-79 were HIV-1 58 
seropositive6; 33 of these positive samples were chosen for attempted HIV-1 59 
sequencing. The sera from SF originated from a study of approximately 6875 60 
patients enrolled in the late 1970s in HBV studies at the San Francisco City 61 
Clinic9. We tested 2231 of these samples from 1978 and found 83 (3.7%) to be 62 
Western blot-positive for HIV-1 antibodies; of these, 20 were randomly chosen for 63 
attempted HIV-1 sequencing. 64 
 65 
Low template number and degradation arising from long-term storage 66 
were major challenges for genomic analysis, as encountered previously with 67 
similar samples10: recovered RNA was generally below the limits of quantitation 68 
and initial attempts at amplification of reverse transcribed viral RNA failed 69 
consistently and indicated viral RNA survived in the 1970s samples only in short 70 
fragments. This led us to design an RNA ‘jackhammering’ approach to greatly 71 
increase both the ability to detect viral RNA-positive samples and to recover 72 
complete genomic HIV-1 sequences from them. Briefly, we use large panels of 73 
primers to amplify many short fragments in separate pools, such that amplicons 74 
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overlap between but not within each pool (ED Fig. 1, Supplementary Table S1). 75 
Each pool’s amplicon set fills gaps between those of complementary pools, with 76 
the entire panel providing complete genomic coverage. A preliminary, multiplex 77 
amplification step, moreover, greatly concentrates target RNA prior to final 78 
amplification and sequencing. 79 
 80 
Three samples from SF and five from NYC provided sufficient data to 81 
assemble coding-complete sequences. Bayesian phylogenetic analyses of these 82 
HIV-1 genomes (Fig. 1, ED Fig. 2) showed that although they are the oldest 83 
sampled outside Africa they do not fall on the deepest branches even within 84 
subtype B. Instead, the 1970s genomes and the US epidemic as a whole are 85 
phylogenetically nested within the more genetically diverse, older subtype B 86 
epidemic in Caribbean countries. Separate analyses of gag, pol and env 87 
sequences also place the US sequences in a strongly supported monophyletic 88 
clade nested within the paraphyletic Caribbean subtype B sequences from Haiti, 89 
Dominican Republic, Jamaica, Trinidad and Tobago, and Haitian immigrants in 90 
the US (ED Figs. 3 and 4). Molecular clock phylogeographic analysis of the 91 
complete genome data supports a subtype B ancestor in the Caribbean (posterior 92 
probability > 0.99) dating to 1967 [95% credibility interval 1963-1970] (ED Table 93 
1). This provides genome-wide evidence that the epidemic moved from the 94 
Caribbean to the US rather than from the US to the Caribbean3. 95 
 96 
Location transition estimates recover a relatively precise date (1971 [1969-97 
73], ED Table 1) for the HIV-1 jump from the Caribbean, very shortly before the 98 
US most recent common ancestor (MRCA). This narrow timing is aided by the 99 
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basal relationship of a very close relative from the Caribbean (sequence “H6,” 100 
from an individual who entered the US from Haiti in 1981)3 (ED Fig. 2). The 101 
probability density of the date of introduction to the US overlaps with the deep 102 
branching structure in Caribbean diversity (Fig. 1, ED Fig. 3), indicating that the 103 
US clade emerged from the Caribbean epidemic during its early growth phase. 104 
We estimated a relatively fast logistic growth rate of 0.62 [0.26,0.99] yr-1 within 105 
the Caribbean population (Fig. 3). That of the US population is even higher, 0.81 106 
[0.65,0.98] yr-1, in line with a precipitous spread among existing high-risk sexual 107 
networks. These mean growth rate estimates correspond to doubling times of 108 
1.12 years and 0.86 years for the Caribbean and the US, respectively; both the 109 
more rapid and longer growth in the US appear to have contributed a higher 110 
number of ‘effective infections’ (Fig. 3), with the US overtaking the Caribbean by 111 
~1977 despite the later HIV-1 emergence in the US. 112 
 113 
Molecular clock analyses of larger numbers of env sequences revealed 114 
similar time of the most recent common ancestor (TMRCA) estimates for the key 115 
nodes (Fig. 2, ED Table 1, ED Fig. 5, ED Fig. 6). Interestingly, our modest 116 
snapshot of 1970s sequences from NYC and SF (Fig. 2, ED Fig. 5b) 117 
encompasses the full diversity exhibited by HIV-1 sequences from later years (i.e. 118 
it shares the same MRCA as larger sequence sets sampled in later years): all 119 
post-1985 sequences US sequences are nested within the early diversity 120 
captured by the limited number of 1970s sequences we recovered (ED Fig. 6) 121 
 122 
A phylogeographic reconstruction including only those US sequences 123 
sampled from known locations between 1978-1984 (Fig. 1) demonstrates that the 124 
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NYC epidemic was already relatively mature and genetically diverse by 1979, 125 
tracing back to an MRCA estimated at 1972 [1970-74], and there is strong 126 
support the US subtype B ancestor circulated in NYC (posterior probability = 127 
0.99). Indeed, the extensive genetic diversity in the US (and in NYC in particular) 128 
in 1978-1979 can only be explained by several years of circulation of the virus 129 
prior to 1978-79.  130 
 131 
Using sequences sampled from NYC, North Carolina and California 132 
relatively late in the epidemic (comparable to the 1978-84 East coast, West coast 133 
and Southern sampling), we still infer a US ancestor in NYC, but with only 134 
modest support that prevents drawing firm conclusions (pp = 0.67, ED. Fig. 6b, 135 
ED Table 1). As a generality, early samples close to the deep branching structure 136 
are essential to confidently reconstruct the initial spatio-temporal expansion 137 
dynamics in exponentially growing populations.  138 
 139 
Compared to NYC, the SF epidemic in 1978 appears to have been 140 
established more recently (Figs. 1 and 2, ED Figs. 2b and 5b). It is striking that all 141 
three independently-detected complete HIV-1 genomes we found are so closely 142 
related; moreover, they form a cluster with three partial env sequences sampled 143 
in SF during the same period10 (ED Fig. 5b). This suggests the bulk of the HIV-1 144 
infections in SF in 1978 traced back to a single introduction from NYC in ~1976 145 
(consistent with the lower HIV-1 seroprevalence in the SF cohort). 146 
 147 
The sampled sequences thus reveal a series of key founder events in the 148 
genesis of subtype B (e.g. Fig. 2, ED Table 1), with the epidemic spreading from 149 
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the African HIV-1 group M epicenter to the Caribbean by ~1967, from the 150 
Caribbean to NYC by ~1971, and from NYC to SF by ~1976 – quickly followed by 151 
extensive geographical mixing in the US and beyond. 152 
 153 
Reports of one cluster of homosexual men with AIDS linked through 154 
sexual contact were important in suggesting the sexual transmission route of an 155 
infectious agent before the identification of HIV-15,11. Beginning in California, 156 
CDC investigators eventually connected 40 men in ten American cities to this 157 
sexual network. Investigators placed one man with Kaposi’s sarcoma (KS) near 158 
the center of a sociogram representing this cluster and identified him as ‘Patient 159 
0’ – a ‘non-Californian AIDS patient’ and a possible ‘carrier’ of an infectious agent 160 
(ED Fig. 7). Before publication, Patient ‘O’ was the abbreviation used to indicate 161 
that this patient with KS resided ‘Out[side]-of-California.’ As investigators 162 
numbered the cluster cases by date of symptom onset, the letter ‘O’ was 163 
misinterpreted as the number ‘0,’ and the non-Californian AIDS patient entered 164 
the literature with that title12. Although the cluster study’s authors repeatedly 165 
maintained that Patient 0 was likely not the ‘source’ of AIDS for the cluster or the 166 
wider US epidemic, many people have subsequently employed the term ‘patient 167 
zero’ to denote an original or primary case, and many still believe the story 168 
today13. We therefore recovered the complete HIV-1 genome of Patient 0 and 169 
examined it against the backdrop provided by the 1970s sequences. 170 
 171 
Though he was labeled as the cluster study’s ‘Index patient’, Patient 0 was 172 
neither the first AIDS case to come to CDC researchers’ attention, nor the first to 173 
display symptoms. In general, the CDC numbered cases in the order that the 174 
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reports reached the agency from different cities and employed the terms ‘cases’ 175 
and ‘patients’ interchangeably. Patient 0, until he was linked to the cluster and 176 
took on his new name, was Case (or Patient) 057. The cluster study’s LA 6 was 177 
the CDC’s Case 032, and several cases in the New York section of the cluster5 178 
(ED Fig. 7) were also reported before Patient 0 (and thus brought to investigators’ 179 
attention first): NY 3 was Case 001, NY 2 was Case 002, NY 6 was Case 010, 180 
and NY 5 was Case 05314. 181 
 182 
The information available to CDC investigators to establish symptom onset 183 
dates was often fragmentary and thus resisted uniform categorization. 184 
Sometimes onset was determined on the basis of lymphadenopathy, other times 185 
by the appearance or diagnosis of Kaposi’s sarcoma or Pneumocystis carinii 186 
pneumonia. Investigators were unable to link to the cluster several NYC-based 187 
cases that had much earlier dates of symptom onset. For example, Case 154 188 
was a middle-aged European man whose reported onset date for KS was 189 
January 1975, and Case 153, when he was diagnosed with KS in September 190 
1981, recalled having swollen glands as early as June 197715. Yet even within 191 
the cluster, Case 057’s symptoms (lymphadenopathy in December 1979, and a 192 
KS lesion diagnosed in May 19805) appeared considerably later than those of 193 
several other cases. LA 1 (Case 335) developed a lesion in February 197816, 194 
while NY 1 (Case 152) experienced the onset of KS in December 1978, NY 2 195 
(Case 002) in May 1979, and NY 3 (Case 001) in August 197914. 196 
 197 
In his book And the Band Played On, Randy Shilts identified ‘Patient Zero’ 198 
by name as a highly sexually active French-Canadian flight attendant17. Unlike 199 
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the initial reports of the cluster, media coverage of Shilts’s book strongly 200 
insinuated that this individual was the source of the North American epidemic and 201 
an exemplar of dangerous disease transmission18 – ideas which found a global 202 
audience (Supplementary Discussion). However, we find that the HIV-1 genome 203 
from this individual appears typical of US strains of the time and is not basal to 204 
the US diversity, let alone to the deeper Caribbean subtype B diversity, in a 205 
manner that might be suggestive of a special role (Figs. 1 and 2). In short, there 206 
is no evidence that Patient 0 was the first person infected by this lineage of HIV-207 
1.  208 
 209 
In addition to donating plasma for analysis, Patient 0 provided 210 
investigators with the names of nearly 10% of his sexual partners over several 211 
years5, while many other cluster patients were unable to share more than a 212 
handful of names16. This strongly suggests ascertainment bias contributed to his 213 
central role in the cluster study and its diagrammatic representation. Later 214 
research would also call into question the cluster study’s estimated average 215 
latency period of 10.5 months between sexual contact and symptom onset, with a 216 
revised average incubation period approaching 10 years for MSM. In retrospect, 217 
the study’s sociogram (ED. Fig. 7) almost certainly depicted the sexual contacts 218 
of these men years after they had contracted HIV-119 (Supplemental Discussion). 219 
Other East coast HIV-1 sequences fall much closer to the main early-California 220 
clade we identify than does that of Patient 0 (Fig. 2). Thus, while he did link AIDS 221 
cases in New York and Los Angeles through sexual contact, our results refute the 222 
widespread misinterpretation that he also infected them with HIV-1. 223 
 224 
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Much like historical reconstructions, phylogenetic inferences are 225 
often generated from data collected long after the critical events occurred. Our 226 
work highlights the importance of complete viral genomes from early archival 227 
specimens, carefully contextualized through historical analysis, without which 228 
this detailed picture of these early landmarks in the HIV/AIDS pandemic would 229 
not   have been possible. 230 
 231 
 232 
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Supplementary Information is linked to the online version of the paper at 303 
www.nature.com/nature. 304 
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Figure legends  340 
 341 
Figure 1: Maximum clade credibility (MCC) tree summary of the Bayesian spatio-temporal 342 
reconstruction based on complete HIV-1 genome data. The tips of the tree correspond to year 343 
of sampling while branch and node colours reflect the sampling location for the tip branches and 344 
the inferred location for the internal branches (AF, Africa; CA, California; CB, Caribbean; GA, 345 
Georgia; NY, New York). Tip labels are provided for the newly obtained archival HIV-1 346 
genomes. Diameters of internal node circles reflect posterior location probability values. Thick 347 
outer circles represent internal nodes with posterior probability support > 0.95. We also depict the 348 
posterior probability density for the time of the introduction event from the Caribbean into the US 349 
on the time scale of the tree. A fully annotated tree for this data set (‘full genome 38’, which 350 
includes only sequences sampled early in the US epidemic) is shown in ED Fig. 2b; ‘full genome 351 
46’ which includes all available complete genomes basal to the “pandemic clade”3 of subtype B, 352 
plus a similar number and date range of US pandemic clade sequences, is shown in ED Fig. 2a. 353 
Separate analyses of gag, pol, env, and the coding-complete genomes (including also sequences 354 
sampled later in the US epidemic) provide consistent results (ED Figs. 3 and 4). 355 
 356 
Figure 2: The early patterns of HIV-1 subtype B spread in the Americas. The map 357 
summarizes the main patterns of spread inferred from the molecular clock phylogeographic 358 
analyses. The map inset shows the initial introduction of the subtype B lineage into the Caribbean 359 
from Africa. From there, the virus first spreads to NY and subsequently to different locations in 360 
the United States. The tree depicts the US clade, plus the most closely related basal HT strain, as 361 
inferred from the ‘env 74’ analysis (ED Fig. 5b). Tips of the clade correspond to the year of 362 
sampling. Tip branch colours reflect the actual sampling locations as indicated on the map; 363 
interior branches depict phylogenetically inferred locations using the same colour scheme. 364 
Diameters of internal node circles reflect posterior location probability values. Thick outer circles 365 
indicate internal nodes with posterior probability support > 0.95. Thickness of the arrows reflects 366 
number of transitions inferred from this tree cluster. Mean dates and 95% credible intervals in 367 
yellow and blue represent the date estimates for the MRCA in the Caribbean and the US, 368 
respectively, based on the env 74 analysis. Date next to arrow between these locations represents 369 
the estimated timing of the corresponding jump.  Patient 0 and the earliest sequences from San 370 
Francisco (1978) and New York City (1979) are labeled. Maps made with Natural Earth. 371 
 372 
Figure 3: Demographic reconstruction based on the nested coalescent model.  373 
The colour scheme is consistent with that of the phylogeographic analyses in Figs. 1 and 2: the 374 
constant-logistic population size estimates (the ‘effective number of infections’, Ne, multiplied by 375 
the mean viral generation time, 𝜏) through time are depicted in a black-yellow color range 376 
(following the African and Caribbean locations in the phylogeographic analyses) while the 377 
logistic population size estimates for the nested US clade are shown in blue (as for the US/NY 378 
location in the phylogeographic analyses).  379 
 380 
 381 
  382 
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Methods 384 
 385 
HIV-1 serological screening of serum samples from San Francisco from 386 
1978. We tested 2231 samples collected from the cohort of gay and bisexual 387 
men in San Francisco in 19789 and detected 83 WB-positives (3.7% prevalence). 388 
Samples were first screened by GS HIV-1/HIV-2 Plus O EIA (Bio-Rad 389 
Laboratories, Redmond WA) and reactive samples were further tested by WB 390 
Genetic Systems HIV-1 Western Blot (Bio-Rad Laboratories, Redmond WA). 391 
 392 
HIV-1 nucleic acid amplification. A total of 33 samples of frozen serum 393 
previously identified as positive for antibody to HIV-16-8 were assayed from New 394 
York City; a total of 20 frozen serum samples from San Francisco9, identified as 395 
part of the present study as positive for antibody to HIV-1, were assayed. The 396 
New York City samples were from 1978 and 1979 though no complete genomic 397 
sequences from 1978 were developed. The San Francisco samples were all from 398 
1978. RNA recovered from samples from both NY and SF was 399 
generally undetectable when assaying 5ul aliquots in a Qubit 2.0 flourometer 400 
using the Qubit RNA HS reagents (detection limit, 250pg/ul). 401 
Additionally, a sample of PMBC and a sample of serum were both 402 
assayed; these had been collected from a single individual in 1983 (Patient 0), 403 
and the samples were stored at CDC Atlanta. Other than Patient 0, now 404 
deceased, the data recorded were unlinked to individual identifiers and the work 405 
was approved by the Human Subjects Protection Program at the University of 406 
Arizona. 407 
Four panels of degenerate primers (Supplementary Table S1, ED Figure 408 
1) were designed using a suite of North American subtype B sequences. We 409 
aimed to design primers able to amplify both conserved regions and predictably 410 
variable sites. Primers within each panel were designed to generate sequence 411 
from the 5’ end of gag to the 3’ end of nef and were designed to amplify 412 
overlapping fragments. Two panels “HIVL” (N=25) and “HIVLb” (N=22) were 413 
designed to amplify fragments of ~500-650 bases in length. Two other panels 414 
“HIVM” (N=50) and “HIVR” (N=46) were designed to amplify fragments of ~200-415 
320 bases in length. 416 
Nucleic acids from 100ul aliquots of serum (or PMBCs in the case of 417 
Patient 0) were isolated using the QIAamp Viral RNA Mini Kit (Qiagen, 418 
Gaithersburg, MD) with 5mg added carrier RNA. Serum samples were then 419 
treated with DNase I (Invitrogen, Life Technologies, Carlsbad, CA) prior to 420 
reverse transcription. PMBC nucleic acids were left untreated. 421 
Proviral DNA from Patient 0’s PMBCs was amplified with all four primer 422 
panels and from multiple separate isolations. Amplification was achieved using 423 
Invitrogen Platinum Taq DNA polymerase High Fidelity (Life Technologies, 424 
Carlsbad, CA) and run for 55 cycles at an annealing temperature of 52oC. 425 
Additionally, attempts were made to amplify longer fragments using PCR 426 
SuperMix High Fidelity (Life Technologies, Carlsbad, CA) and forward and 427 
reverse primers matched from the HIVLb primer panel for long fragment length 428 
followed by nesting with primers for slightly shorter fragment length. A single 429 
fragment of slightly more than 7000 bases was generated after multiple attempts 430 
with multiple primer combinations and cloned using the Invitrogen TOPO XL PCR 431 
Cloning Kit (Life Technologies, Carlsbad, CA). Fragments of individual clones 432 
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were then amplified using HIVLb forward and reverse primers matched to give 433 
approximately 1000-base overlapping fragments and then sequenced. 434 
 435 
 436 
RNA jackhammering. RNA jackhammering of the serum samples proceeded as 437 
follows: Aliquots of RNA extract were reverse transcribed using the GoScript 438 
Reverse Transcription System (Promega, Madison, WI) using a program of 4 439 
cycles of 50oC for 30’ followed by 55oC for 30’ and an 85oC final incubation. 440 
Primers used were pools of reverse primers from widely spaced amplicons 441 
(Supplementary Table S1, ED Fig. 1), typically nine or ten primers per pool in a 442 
single reaction tube, with the wide spacing abrogating the possibility of 443 
incorporation of an internal primer into any given amplicon. RT products were 444 
then briefly amplified in multiplex reactions in the pool-specific tube (denaturation 445 
for 3’ at 94oC followed by 30 cycles of 94oC for 30”, 52oC for 30”, 68oC for 30”, 446 
and a final extension of 68oC for 5’) with matching forward primer pools (a 447 
“preliminary amplification” step). Sequences were then amplified from individual 448 
aliquots taken from the pool-specific tubes, via single primer pairs (denaturation 449 
for 3’ at 94oC followed by 40 cycles of 94oC for 30”, 52oC for 30”, 68oC for 30”, 450 
and a final extension of 68oC for 5’). Two separate isolates were amplified from 451 
each sample in this manner, with a minimum of one amplification with each 452 
primer panel per isolate. Five out of the 33 (15%) of the NY sera assayed yielded 453 
complete HIV-1 genomic data as did 3 out of the 20 (15%) SF sera, suggesting 454 
that levels of viral RNA preservation were very similar in each collection. 455 
In ED Fig. 1 we schematically illustrate the RNA jackhammering approach 456 
and its advantages over standard RT-PCR procedures for degraded, low input 457 
samples. For a conventional RT-PCR approach with a fairly long amplification 458 
product we would perform RT and obtain one potentially amplifiable cDNA 459 
product. We would then aliquot ~10% of the RT product for amplification in a 460 
PCR reaction with forward and reverse primers. Even if the single cDNA product 461 
made it into the PCR reaction, the desired amplification product would be too 462 
long, and a PCR amplicon would therefore not be obtained. For RT-PCR with a 463 
shorter amplification product, more appropriately sized given the damaged RNA 464 
in the sample, there is still a 90% chance that it would be deemed a negative 465 
sample since most aliquots will not contain the rare cDNA product. Using multiple 466 
primer sets will increase the chance of a PCR-positive result, but most PCR 467 
reactions remain negative because most aliquots lack target cDNA. Even with a 468 
10 primer-pair pool and 10 final PCR reactions, there may be no amplified 469 
product. The RNA jackhammering approach targets large panels of appropriately 470 
short amplicons, uses discrete pools of non-overlapping primers pairs for RT, and 471 
includes a crucial multiplex pre-amplification step to ensure that each aliquot 472 
contains ample template molecules for the final PCR amplifications (a separate 473 
reaction for each primer pair in the entire panel). 474 
Sequencing was performed at the University of Arizona Genetics Core 475 
using an ABI 3730XL. The Patient 0 sample contained considerable 476 
heterogeneity (mixed bases) both in proviral assembly and in viral RNA 477 
amplifications. Heterogeneity in the NY and SF samples (all sequences derived 478 
from viral RNA) was low. In all cases consensus sequences were used in the 479 
phylogenetic analyses. Primer sequences were computationally removed from all 480 
sequence data prior to assembling genomic consensus sequences, which yielded 481 
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coding-complete genomic data with exception of a few small gaps and the 3’ end 482 
of the nef gene (Supplementary Table S2). 483 
 484 
Validation of the jackhammering approach. To validate this approach we 485 
obtained seed stock samples from the NIH AIDS Reagent program of subtype B 486 
viruses from the US (US657) and Haiti (HT599) and applied a jackhammering 487 
approach with independent runs of both the HIVM and HIVR primer panels (ED 488 
Fig. 8). 489 
For US657 we recovered, in total, from both runs combined, 8194nt of 490 
high quality data. HIVM and HIVR are independent runs with completely different 491 
primer sets, yet where the data overlapped, they were >99.9% similar. Moreover, 492 
the few heterogeneities did not line up with heterogeneous primers but fell in 493 
regions between primers, demonstrating that differences could not be attributed 494 
to the incorporation of primers into the recovered sequences. This was expected 495 
both because the wide spacing of amplicons within a single pool of primer pairs 496 
prevents incorporation of primers within amplified products and because all 497 
primer sequences from final amplification products were computationally 498 
removed from the sequences prior to assembly of genomic sequences. There are 499 
3354 bases in the published US657 sequence. Our data covered about 90% of 500 
the 3354 bases of previously published US657 sequence (GenBank accession 501 
number U04908) and all of our individual amplicons in the region of overlap had 502 
US657 as the highest BLAST hit and were >99% similar to the published 503 
sequence. 504 
For HT599 the HIVM and HIVR primer panels developed 8545nt of data, 505 
99.6% of the target. HIVM-derived sequence was >99.9% similar to HIVR-derived 506 
sequence. We recovered 100% of the overlap with the previously published 507 
HT599 sequence (2881nt, GenBank accession number U08447) with 99.5% 508 
similarity. 509 
To evaluate discrepancies between the jackhammering-recovered 510 
sequences and both US657 and HT599, we compared consensus sequences of 511 
combined HIVM and HIVR data with the respective published sequences by 512 
adding them to our complete genome alignment and reconstructing a maximum 513 
likelihood tree (ED Fig. 8a). As expected, the independently generated 514 
sequences from each virus cluster very closely and only have short tips from their 515 
common ancestors, resulting from a very small number of substitutions in their 516 
overlapping regions. In a regression analysis (ED Fig. 8b), our sequences (with a 517 
target symbol) are associated with somewhat smaller residuals then the 518 
published sequences (with a circle), indicating our data are likely to be more 519 
accurate and, importantly, cannot contain primer remnants as this would result in 520 
much larger residuals. 521 
 522 
Sequence data. To construct the data sets for the analyses in Fig. 1 and ED 523 
Figs. 2-4 we searched the Los Alamos National Laboratories (LANL) HIV 524 
database (http://hiv.lanl.gov/) for all available genome-length HIV-1 sequences 525 
from Caribbean countries, which had previously been shown to exhibit diverse 526 
subtype B lineages that fall basal to a monophyletic “pandemic” clade of subtype 527 
that accounts for most US and other non-Caribbean subtype infections3. These 528 
included sequences sampled in Haiti, Dominican Republic, Jamaica, and from 529 
Haitians who had recently immigrated to the US from Haiti (“H3” and “H5” from 530 
1982, and “H6” and “H7” from 1983, “RF_HAT” from 1983)3. For sequences H3, 531 
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H5, H6 and H7 pol sequences were not available, but partial gag and full length 532 
env sequences were available. For the full genome analyses the pol gene was 533 
treated as missing data. We then added a similar number of genomes from the 534 
US from a similar time period (1982-2005), plus one each from France and the 535 
U.K., as well as outgroup sequences of subtype D from the Democratic Republic 536 
of the Congo (D.R.C.). We called this the “full genome 46” data set because it 537 
contained 46 genomes. The gag, pol, and env data sets depicted in ED Fig. 3 538 
were each derived from the respective sub-genomic region of this same set of 539 
taxa. The subset of “full genome 46” that contained only those US sequences 540 
sampled from 1978-84 we called “full genome 38”. 541 
For the env analyses in Fig. 2 and ED Fig. 5 the alignment from ref. 3 was 542 
used, with the addition of the sequences generated for the present study, 543 
additional Caribbean subtype B sequences from 2000-2005, and four early 544 
subtype B partial env sequences from San Francisco10. This alignment we called 545 
“env 105”. The subset that contained only those US sequences sampled from 546 
1978-84 we called “env 74”. 547 
For ED Fig. 6 we added to “env 105” a comparable number – relative to 548 
those sampled from 1978-1984 from known locations (NY, CA, GA, PA, NJ) (ED 549 
Fig. 4b) – of randomly sampled sequences from 1997-2007 from NY, SF, and 550 
North Carolina (NC) (the closest available site with sufficient numbers to stand in 551 
for the Georgia ones from the 1978-84 sample). We called this alignment “env 552 
133”. 553 
In all cases sequences were manually aligned using Se-Al 554 
(http://tree.bio.ed.ac.uk/software/seal/). All sequence alignments, input files, tree 555 
files and primer sequences are available at the Dryad Digital Repository 556 
(doi:10.5061/dryad.7mv7v). 557 
 558 
Recombination analysis and maximum likelihood tree reconstruction. 559 
Maximum likelihood (ML) phylogenies were reconstructed using RAXML under 560 
on a general time-reversible model of substitution with gamma distributed rate 561 
variation among sites18. Bootstrap support values were calculated using 1000 562 
pseudo-replicates. To detect the presence of recombination, we first performed 563 
the Phi test19 on every data set (ED Table 1). When the null hypothesis of 564 
absence of recombination was rejected (P < 0.05), we subsequently analyzed the 565 
data set using RDP420 and produced new alignments in which the minor 566 
recombinant regions were deleted from putative recombinants. Re-analyses of 567 
these ‘recombination-free’ data sets using the Phi test confirmed the absence of 568 
detectable recombination signal (P > 0.05, ED Table 1). 569 
 570 
Bayesian phylogenetic inference. Time-measured phylogeographic histories 571 
were reconstructed using a Bayesian phylogenetic inference approach 572 
implemented in BEASTv1.8.221. Our full probabilistic model combined sequence 573 
substitution over an unknown phylogeny calibrated in time units using a 574 
molecular clock process with dated tips22, a coalescent tree prior and a discrete 575 
diffusion process among discrete location states23. For the sequence substitution 576 
process, we used the same model as for the ML reconstructions. We 577 
accommodated rate variation among lineages using a lognormal distribution in an 578 
uncorrelated relaxed molecular clock model24 and integrated out each sampling 579 
date over an uncertainty interval of one year. Visual inspections of root-to-tip 580 
 19 
divergence as a function of sampling time using TempEst25 indicated strong 581 
temporal signal with no clear outlier sequences (ED Fig. 9). 582 
For most analyses, we flexibly modeled changes in effective population 583 
size through time by specifying a Bayesian skygrid non-parametric tree prior with 584 
a grid of 50 years and yearly effective population size parameters26. (The notion 585 
of ‘effective population size’, or ‘effective infections’ in epidemiological 586 
applications, comes from population genetics, and is typically lower than the full 587 
(i.e. census) population size, reflecting for example variance in reproductive 588 
success among individuals – transmissions to new hosts in this context). To 589 
estimate viral population growth rates in both the Caribbean and US population, 590 
we fitted a ‘nested’ coalescent model to the data set with the largest taxon 591 
sampling (env 133). This model fits a constant-logistic demographic function27 to 592 
the genealogy excluding the US clade. The initial constant phase was included in 593 
the model to accommodate the deep branching between the subtype B 594 
sequences and the African subtype D outgroup sequences. Nested within this 595 
model, a separate logistic growth model was fitted to the US clade in the 596 
genealogy. 597 
The process of discrete diffusion among locations was modeled using a 598 
general non-reversible substitution model28. In our analyses including the African 599 
subtype D outgroup lineages, we set the root state frequency to one for the 600 
African state and zero for all other possible discrete states. We obtained 601 
estimates of the transitions among locations (Markov jumps) using a stochastic 602 
mapping implementation capable of inferring the complete Markov jump 603 
history29,30. We approximate the posterior distribution for our full probabilistic 604 
model using Markov chain Monte Carlo (MCMC) sampling. We use BEAGLE in 605 
conjunction with BEAST to improve the computational performance of our 606 
analyses31. MCMC chains were run for 50,000,000 generations, sampling every 607 
5,000 generations. We diagnosed the runs by examining trace plots and effective 608 
samples sizes, and summarized continuous parameters (mean and 95% highest 609 
posterior density [HPD] intervals) using Tracer 610 
(http://tree.bio.ed.ac.uk/software/tracer/) after discarding a 10% burn-in. Trees 611 
were summarized as maximum clade credibility trees using TreeAnnotator and 612 
visualized in FigTree (http://tree.bio.ed.ac.uk/software/figtree/). 613 
In two specific phylogeographic analyses we assess i) to what extent 614 
sequences sampled early in the US epidemic characterize the subtype B diversity 615 
in the US clade (ED Fig. 6a) and ii) to what extent the location state at the origin 616 
of the US clade can be estimated using sequences sampled later in the epidemic 617 
from three different US states (ED Fig. 6b). For this purpose, we first 618 
reconstructed time-measured phylogenies for the env 133 data set using the 619 
substitution model, molecular clock model and coalescent model described 620 
above and subsequently reconstructed ancestral locations on the inferred 621 
posterior distribution of trees. 622 
For ED Fig. 6a we classified US sequences as ‘early’ or ‘late’ depending 623 
on whether they were sampled before or after (and including) 1985. For ED Fig. 624 
6b, we first pruned the necessary US sequences from the posterior distributions 625 
in order to retain only ‘late’ sequences from NY, NC and CA (matching the 626 
sampling from NY, GA and CA in Fig. 2 and ED Fig. 5b). In this case, the support 627 
for a NYC ancestral state is likely upheld by the presence of two basal NYC 628 
representatives, but location estimates in a star-like tree structure with long tip 629 
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branches will be critically dependent on how well the diversity of any location is 630 
represented in the contemporaneous sampling, as recently noted32. 631 
Comparison of phylogeographic estimates before and after deleting minor 632 
recombinant regions from putative recombinants (ED Table 1) indicated highly 633 
consistent results.  634 
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ED Legends  681 
 682 
ED Table 1: Molecular clock, phylogeographic and recombination estimates for the 683 
different data sets 684 
*The recombination free (“recomb. free”) data sets were obtained by deleting the minor recombinant 685 
regions from the putative recombinants identified using RDP4. 686 
†the empirical trees from the “env 133” analysis were used for two different ancestral reconstructions (ED 687 
Fig. 6); here we list the location estimates for the analysis that considered different US states for the late 688 
samples (ED Fig. 6b). 689 
 690 
Extended Data Figure 1: Jackhammering schematic and primer panels and pools. a through 691 
d: detection and amplification of target RNA molecules in old, degraded, low-titre samples. For 692 
the purposes of illustration, consider a tube with 10
13 
RNA molecules, but (because of the low 693 
RNA quality) only one molecule that is (i) capable of being primed by the given reverse primer(s) 694 
and (ii) long enough to form a 200bp product. a, conventional RT-PCR with a long amplification 695 
product, oversized for a sample with RNA less than ~200 bases in length. b, RT-PCR with a 696 
shorter amplification product. c, use of multiple primer pairs to increase the chance of a at least 697 
one PCR-positive result. d, the jackhammering approach, which overcomes the problems 698 
encountered in a through c by (i) targeting an extensive panel of short amplicons appropriately 699 
sized to the level of RNA survival in the sample, (ii) conducting RT with pools of primer pairs 700 
that amplify discrete, non-overlapping genomic regions, and (iii) employing a multiplex pre-701 
amplification step, in the tube with the RT product, to generate sufficient DNA to ensure that each 702 
aliquot from it contains numerous template molecules for final PCR amplification. In this 703 
schematic, we show just two primer pairs per pool, but we used pools of ten pairs with our largest 704 
primer panels (shown in panel e, HXB2 numbering along HIV-1 genome). With a 10 primer-pair 705 
pool, and 10 final reactions, one can reliably recover 10 bands for sequencing. Five such pools 706 
(one entire panel of 50 pairs), allows for complete HIV-1 genome recovery even in heavily 707 
degraded samples. 708 
 709 
Extended Data Figure 2: Maximum clade credibility (MCC) tree summaries of Bayesian 710 
spatio-temporal reconstructions based on complete HIV-1 genome data (a: “full genome 711 
46”, b: “full genome 38”). The tips of the trees correspond to the year of sampling while the 712 
branch (and node) colours reflect location: the sampling location for the tip branches and the 713 
inferred location for the internal branches (AF, Africa; CB, Caribbean; US, the United States; CA, 714 
California, GA, Georgia; NY, New York). The diameters of the internal node circles reflect 715 
posterior location probability values. Thick outer circles represent internal nodes with posterior 716 
probability support > 0.95. Grey bars indicate the 95% credibility intervals for the internal node 717 
ages. The tree in b) represents the fully annotated version of the tree in Fig. 1 in the main 718 
manuscript. 719 
 720 
Extended Data Figure 3: Maximum clade credibility (MCC) tree summaries of Bayesian 721 
spatio-temporal reconstructions based on different genome region data sets. MCC trees for 722 
the same strains are shown for a) gag, b) pol, c) env and d) the complete genome. The tips of the 723 
trees correspond to the year of sampling while the branch (and node) colours reflect location: the 724 
sampling location for the tip branches and the inferred location for the internal branches (AF, 725 
Africa; CB, Caribbean; US, the United States). Tip labels are provided for the newly obtained 726 
archival HIV-1 genomes. The diameters of the internal node circles reflect posterior location 727 
probability values. Thick outer circles represent internal nodes with posterior probability support 728 
> 0.95. We also depict the posterior probability densities for the time of the introduction event 729 
from the Caribbean into the U.S on the time scale of the trees. 730 
 731 
Extended Data Figure 4: Maximum likelihood phylogenies for the different genome region 732 
data sets. We analyzed the same data sets as in ED Fig. 3. The diameters of the internal node 733 
circles reflect bootstrap support values. We manually colored the branches in a similar way as for 734 
the Bayesian phylogeographic reconstructions. 735 
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 736 
Extended Data Figure 5: Maximum clade credibility (MCC) tree summaries of Bayesian 737 
spatio-temporal reconstructions based on different env data sets (a: “env 105”, b: “env 74”). 738 
The tips of the trees correspond to the year of sampling while the branch (and node) colours 739 
reflect location: the sampling location for the tip branches and the inferred location for the 740 
internal branches (AF, Africa; CB, Caribbean; US, the United States, CA, California; GA, 741 
Georgia; NJ, New Jersey, NY, New York; PA, Pennsylvania). The diameters of the internal node 742 
circles reflect posterior location probability values. Thick outer circles represent internal nodes 743 
with posterior probability support > 0.95. We also depict the posterior probability density for the 744 
time of the introduction event from the Caribbean into the U.S on the time scales of the trees. The 745 
three partial env sequences from SF in 1978
10
 are highlighted with bullets. 746 
 747 
Extended Data Figure 6: Maximum clade credibility (MCC) tree summaries of Bayesian 748 
spatio-temporal reconstruction comparing early and late strains (a: “env 133”, b: only 749 
“late” sequences from “env 133”). In a), we classified US sequences as ‘early’ or ‘late’ 750 
depending on whether they were sampled before or after (and including) 1985. In b), the analysis 751 
was conducted on an empirical tree distribution of “env 133” from which we pruned early US 752 
sequences (in grey), but we still annotate the reconstruction on the complete phylogenies for 753 
reference. The tips of the tree correspond to the year of sampling while the branch (and node) 754 
colours reflect location: the sampling location for the tip branches and the inferred location for the 755 
internal branches (AF, Africa; CB, Caribbean; US early, the United States sampled < 1985; US 756 
late, the United States sampled in or after 1985; CA, California; GA, Georgia; NC, North 757 
Carolina, NY, New York). The diameters of the internal node circles reflect posterior location 758 
probability values. Thick outer circles represent internal nodes with posterior probability support 759 
> 0.95. 760 
 761 
Extended Data Figure 7: A cluster of 40 early AIDS patients linked through sexual contact 762 
(Reprinted from Figure 1 of reference 5 with permission from Elsevier). 763 
 764 
Extended Data Figure 8: Jackhammering validation with reference viruses. a, The consensus 765 
sequences for primer panels HIVM and HIVR (‘RMcon’ suffix) were included, with previously 766 
published sequences for a US (US657) virus and a Haitian (HT599) virus, in a maximum 767 
likelihood tree. The two clusters of paired sequences are highlighted by coloured boxes. b, Plot of 768 
the root-to-tip genetic distance against sampling time for the tree in a). The colors for the data 769 
points are consistent with those used for sampling locations in the phylogenies (the two African 770 
outgroup tips are not shown for clarity). The data points with black circles represent the published 771 
sequences while the data points with a target symbol represent the newly obtained sequences. 772 
 773 
Extended Data Figure 9: Plots of the root-to-tip genetic distance against sampling time for 774 
different genome region data sets (gag, pol, env and complete genome). We used TempEst
25
 to 775 
obtain exploratory regressions based on the maximum likelihood trees (ED Fig. 4). Each data 776 
point represents a tip; colors are consistent with those used for sampling locations in the 777 
phylogenies. The US data points with black circles represent the new genomes dating back to 778 
1978-1979. The data point with the target symbol represents the Patient 0 genome. In each plot, 779 
we provide the R
2
 for the regression and the slope, reflecting the evolutionary rate (in 780 
substitutions per site per year). 781 
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